Siemens Healthineers Launches an Industry-leading Menu for Core Lab Capillary Testing on Atellica Analyzers with Claims for 24 Assays
Tarrytown, New York, USA, July 23, 2026 (GLOBE NEWSWIRE) -- Siemens Healthineers announced today that it has launched capillary testing on the Atellica CH, IM, and CI Analyzers after receiving CE-mark for 24 capillary blood testing claims [1], an advancement for capillary testing that offers clinical labs greater confidence in test results and higher throughput. Capillary testing on the Atellica analyzers supports the most common laboratory testing needs – including key assays that comprise
Tarrytown, New York, USA, July 23, 2026 (GLOBE NEWSWIRE) --
Siemens Healthineers announced today that it has launched capillary testing on the Atellica CH, IM, and CI Analyzers after receiving CE-mark for 24 capillary blood testing claims [1], an advancement for capillary testing that offers clinical labs greater confidence in test results and higher throughput. Capillary testing on the Atellica analyzers supports the most common laboratory testing needs – including key assays that comprise the comprehensive metabolic panel, lipid panels, thyroid, Vitamin D, and HbA1c. Blood collection for capillary testing is mostly done through a finger prick or heel stick, rather than a standard blood draw (venipuncture) where a needle is inserted directly into a vein, offering greater flexibility for diverse patient testing needs.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.